Cell MedX Corp. (OTCMKTS:CMXC – Get Free Report)’s stock price traded down 7.4% on Monday . The stock traded as low as $0.40 and last traded at $0.40. 6,448 shares traded hands during mid-day trading, a decline of 68% from the average session volume of 20,342 shares. The stock had previously closed at $0.4320.
Cell MedX Stock Down 7.4%
The company’s fifty day moving average price is $0.33 and its two-hundred day moving average price is $0.35.
About Cell MedX
Cell MedX Corp., a biotech company, discovers, develops, and commercializes therapeutic and non-therapeutic products for patients with diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney functions in the United States. The company develops and manufactures eBalance Pro System for professional use by healthcare practitioners in a clinical setting; and eBalance Home System for home use for general wellness and pain management treatment, which are controlled by the eBalance Console that acts as the central controller for three pre-programmed microcurrent algorithms, including wellness, pain management, and dual.
Featured Stories
- Five stocks we like better than Cell MedX
- Differences Between Momentum Investing and Long Term Investing
- Semiconductor Supercycle: Why Onsemi Stock Could Double as AI and EV Growth Accelerate
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- The Best Local Butchers for Thanksgiving [2025 Survey]
- Value Investing: Is it a Good Strategy in 2022? (Hint: Always)
- $134M in Insider Moves: What It Might Mean for KMI, ISRG and QS
Receive News & Ratings for Cell MedX Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cell MedX and related companies with MarketBeat.com's FREE daily email newsletter.
